Corcept Therapeutics | Pasivo Circulante





Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Alaunos Therapeutics USD 921K 153K 2025-09
ANI Pharmaceuticals USD 270.56M 33.72M 2025-09
Ardelyx USD 83.39M 1.67M 2025-09
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 124.12M 32.76M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 81.1M 17.56M 2025-09
Corcept Therapeutics USD 172.26M 27.6M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 359.03M 60.24M 2025-09
J&J USD 54.13B 3.26B 2025-12
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 32B 286M 2025-09
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 107.08M 206.09M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Supernus Pharmaceuticals USD 330.63M 44.27M 2025-09
TG Therapeutics USD 156.81M 15.08M 2025-09


Corcept Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.